Dark History, Bright Future?: The Ethical Conundrum of Eugenics and Genomics
By Alexander Capron
| 04. 26. 2007
A talk given at the ESRC Genome Policy and Research Forum at the University of Edinburgh, Scotland
It is a cliché to suggest that we are standing at the edge of a new age, but in terms of genetic science, that cliché is an understatement. Just as the great gains in theory and methodology achieved by physicists early in the 20th century produced both an exponential growth in understanding and applications of that knowledge that transformed human affairs, so the work of genetic researchers in the last decade of the 20th century set the stage for what I am sure we all agree will be equally astonishing theoretical and practical transformations in biology in this century.
There has, of course, been a great deal of hype as well. The tendency to claim "breakthrough" for every research finding, especially those related to grave human diseases, is visible on a daily basis in the media, as well as in more scientific settings. This tendency, which is born both of intellectual excitement and simple pride, driven as well by the competition for research funding and by the imperatives of University publicity departments, carries the potential for backlash.
Yet, even if...
Related Articles
Since the “CRISPR babies” scandal in 2018, no additional genetically modified babies are known to have been born. Now several techno-enthusiastic billionaires are setting up privately funded companies to genetically edit human embryos, with the explicit intention of creating genetically modified children.
Heritable genome editing remains prohibited by policies in the overwhelming majority of countries that have any relevant policy, and by a binding European treaty. Support for keeping it legally off limits is widespread, including among scientists...
By Sophie Alexander and Ike Swetlitz, Bloomberg | 06.25.2025
A California-startup focused on genetically editing human embryos — a step toward creating so-called designer babies — is raising money as many of Silicon Valley’s ultra-rich turn their attention to one of the most controversial technologies in medicine.
Bootstrap Bio...
By Ed Cara, Gizmodo | 06.22.2025
In late May, several scientific organizations, including the International Society for Cell and Gene Therapy (ISCT), banded together to call for a 10-year moratorium on using CRISPR and related technologies to pursue human heritable germline editing. The declaration also outlined...
By Antonio Regalado, MIT Technology Review | 06.05.2025
Brian Armstrong, the billionaire CEO of the cryptocurrency exchange Coinbase, says he’s ready to fund a US startup focused on gene-editing human embryos. If he goes forward, it would be the first major commercial investment in one of medicine’s most...